½ÃÀ庸°í¼­
»óǰÄÚµå
1597829

ÁÖ»ç±â ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Syringes Market by Type (Disposable Syringes, Prefilled Syringes, Sterilizable or Reusable Syringes), Application (Blood Specimen Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÁÖ»ç±â ½ÃÀåÀº 2023³â¿¡ 102¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 107¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.76%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 141¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÁÖ»ç±â ½ÃÀåÀº ÀÇ·á±â±â »ê¾÷¿¡¼­ Áß¿äÇÑ ºÎ¹®À¸·Î ÇÇÇÏ ÁÖ»ç±â, ¾ÈÀü ÁÖ»ç±â, Àν¶¸° ÁÖ»ç±â µî ´Ù¾çÇÑ À¯ÇüÀ» Æ÷ÇÔÇÏ´Â ±¤¹üÀ§ÇÑ ¹üÀ§¿Í Á¤Àǰ¡ Ư¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ÀǾàǰ, ¹é½Å ¹× ±âŸ ¼ö¾×À» Åõ¿©ÇÏ´Â µ¥ ÇʼöÀûÀÌ¸ç º´¿ø, Áø·á¼Ò ¹× ÀçÅÃÄ¡·á¿Í °°Àº ÀÇ·á ȯ°æ¿¡¼­ Çʼö ºÒ°¡°áÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÁÖ»ç±âÀÇ Çʿ伺Àº ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ´ç´¢º´°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¤±âÀûÀÎ ÀÇ·á °³ÀÔÀÌ ÇÊ¿äÇÑ Àü ¼¼°è °í·ÉÈ­·Î ÀÎÇØ ´õ¿í °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ù´Ã¿¡ Âñ¸®´Â ¼Õ»óÀ» ¹æÁöÇϱâ À§ÇÑ ¾ÈÀü ÁÖ»ç±â äÅÃÀÌ ½ÃÀåÀ» ´õ¿í °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎÀ¸·Î´Â ½º¸¶Æ® ÁÖ»ç±â¿Í °°Àº ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, ¿¹¹æÁ¢Á¾À» Àå·ÁÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ÇÃ¶ó½ºÆ½ Æó±â¹°¿¡ ´ëÇÑ ¿ì·Á, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, °í±Þ ÁÖ»ç±â¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù. Çõ½ÅÀÇ ±æÀº ȯ°æ ¹®Á¦¿Í ºñ¿ë È¿À²¼ºÀ» ÇØ°áÇϱâ À§ÇÑ »ýºÐÇØ¼º ¹× Àç»ç¿ë °¡´ÉÇÑ ÁÖ»ç±â ±â¼ú°ú ¿ë·® ÃßÀû ¹× Åõ¾à È¿À²À» ³ôÀ̱â À§ÇÑ µðÁöÅÐ ±â¼ú°úÀÇ ÅëÇÕ¿¡ ÀÖ½À´Ï´Ù. ÀÇ·á º¸±ÞÀÌ È®´ëµÇ°í ÀÖ´Â ½ÅÈï±¹ ½ÃÀåÀÇ È®´ë¿Í Á¾¾çÇÐ, ¼öÀÇÇÐ µî Æ´»õ ½ÃÀå¿ë ÁÖ»ç±â ½ÃÀå °³Ã´¿¡µµ ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ±×·¯³ª À§Á¶Ç°¿¡ ´ëÇÑ Ç°Áú À¯Áö¿Í °ø±Þ¸Á È¥¶õ¿¡ ´ëÇÑ ´ëÀÀ µîÀÇ °úÁ¦´Â ÁøÀüÀ» °¡·Î¸·´Â Àå¾Ö¹°ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸¿Í ºñÁî´Ï½º ¼ºÀåÀº Áö¼Ó °¡´ÉÇÑ Àç·á, ½º¸¶Æ® ÁÖ»ç±â ½Ã½ºÅÛ, ¾ÈÀü ±â´É °­È­¿¡ ÃÊÁ¡À» ¸ÂÃß¾î¾ß ÇÕ´Ï´Ù. ÁÖ»ç±â ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, ¾ÈÀü, Áö¼Ó°¡´É¼º, ½º¸¶Æ® ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÇöÀçÀÇ ¿ä±¸¸¦ ÃæÁ·½Ãų »Ó¸¸ ¾Æ´Ï¶ó ¹Ì·¡ÀÇ Æ®·»µå¸¦ ¿¹ÃøÇÏ´Â º¸´Ù ÅëÇÕÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀ» ¾Ï½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ä¼Ò¿¡ ´ëÀÀÇÏ¸é °æÀï·ÂÀ» ³ôÀÌ°í ½ÃÀå Á¡À¯À²À» È®´ëÇϸç, µµÀüÀûÀ̸鼭µµ ºü¸£°Ô ¼ºÀåÇÏ´Â ºÐ¾ß¿¡¼­ ¿µÇâ·ÂÀ» ³ôÀÏ ¼ö ÀÖ´Â ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 102¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 107¾ï ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 141¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 4.76%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÁÖ»ç±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÁÖ»ç±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ö¼ú °Ç¼ö Áõ°¡
    • ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü, ³ë·ÉÀα¸ Áõ°¡, ¾ÈÀü ÁÖ»ç±â äÅà Áõ°¡
    • ¹é½Å ¼ö¿ä Áõ°¡ ¹× ÀÇ·áºñ ÁöÃâ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÁÖ»ç±âÀÇ ³ôÀº ºñ¿ë, ¹Ù´Ã¿¡ Âñ¸®´Â ¼Õ»ó ¹ß»ý·ü Áõ°¡
  • ½ÃÀå ±âȸ
    • ħ Âñ¸² ¼Õ»ó¿¡ ´ëÇÑ Àνİú ÀÇ·á ¼¾ÅÍÀÇ Áö¼ÓÀûÀÎ ÀÇ·á °üÇà °³¼±
    • ÁÖ»ç±â ±â¼ú ¹ßÀü¿¡ µû¸¥ ÁÖ»çÁ¦ äÅÃ
    • Àν¶¸° µî ÀÚ°¡ÁÖ»çÁ¦ ÀÌ¿ë »ç·Ê Áõ°¡, »ý¹°ÇÐÀû Á¦Á¦ °³¹ß
  • ½ÃÀå °úÁ¦
    • ´ëü ¾à¹° Àü´ÞÀÇ °¡´É¼º°ú ÁÖ»çÁ¦ÀÇ ¹«±Õ¼º

Portre's Five Forces: ÁÖ»ç±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÁÖ»ç±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÁÖ»ç±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÁÖ»ç±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ÁÖ»ç±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÁÖ»ç±â ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÁÖ»ç±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ»ç±â ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ ÁÖ»ç±â ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸³´Ï´Ù.

ÁÖ»ç±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÁÖ»ç±â ½ÃÀå : À¯Çüº°

  • ÀÏȸ¿ë ÁÖ»ç±â
  • »çÀü ÀÔ·Â ÁÖ»ç±â
  • ¸ê±Õ °¡´É ¶Ç´Â ÀçÀÌ¿ë °¡´É ÁÖ»ç±â

Á¦7Àå ÁÖ»ç±â ½ÃÀå : ¿ëµµº°

  • Ç÷¾× °Ëü äÃë
  • Drug Delivery
  • ¿¹¹æ Á¢Á¾

Á¦8Àå ÁÖ»ç±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • °¡Á· Áø·á
  • ºÒÀÓ Ä¡·á ȯÀÚ
  • º´¿ø ¹× HMO

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ»ç±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ»ç±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ»ç±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • B. Braun Melsungen AG
  • Baxter Healthcare Corporation
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Codan Medizinische Gerate GmbH & Co KG
  • Gerresheimer AG
  • Hindustan Syringes & Medical Devices Ltd.
  • JMI Syringes & Medical Devices Limited
  • McKesson Medical-Surgical Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Medical Corporation
  • Schott AG
  • Smiths Medical by ICU Medical Inc.
LSH

The Syringes Market was valued at USD 10.23 billion in 2023, expected to reach USD 10.70 billion in 2024, and is projected to grow at a CAGR of 4.76%, to USD 14.17 billion by 2030.

The market for syringes is a critical segment within the medical devices industry, characterized by its extensive scope and definition which includes different types such as hypodermic, safety, and insulin syringes. These devices are essential for administering medications, vaccines, and other fluids, making them indispensable across healthcare settings including hospitals, clinics, and home care. The need for syringes is underscored by the rising demand for vaccinations, increasing prevalence of chronic diseases such as diabetes, and the aging global population which requires regular medical interventions. Additionally, the adoption of safety syringes to prevent needlestick injuries further drives the market. Factors influencing growth include technological advancements like smart syringes, increased healthcare spending, and government initiatives promoting immunization. However, market growth is constrained by factors such as concerns over plastic waste, stringent regulatory requirements, and the high costs associated with advanced syringes. Innovative avenues lie in biodegradable and reusable syringe technology to address environmental concerns and cost-effectiveness, as well as integration with digital technologies for dose tracking and administration efficiency. Opportunities exist in expanding markets of emerging economies where healthcare penetration is increasing, along with the development of syringes for niche applications such as oncology and veterinary medicine. Yet, challenges such as maintaining quality against counterfeiting and managing supply chain disruptions can impede progress. Research and business growth should focus on sustainable materials, smart syringe systems, and enhanced safety features. The syringe market is dynamic, with a growing emphasis on safety, sustainability, and smart technologies, suggesting a move towards more integrated healthcare solutions that not only meet current needs but also anticipate future trends. Addressing these elements can provide a competitive edge, paving the way for increased market share and influence in a challenging yet burgeoning sector.

KEY MARKET STATISTICS
Base Year [2023] USD 10.23 billion
Estimated Year [2024] USD 10.70 billion
Forecast Year [2030] USD 14.17 billion
CAGR (%) 4.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Syringes Market

The Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of surgical procedures
    • High prevalence of chronic diseases, rising geriatric population, and increasing adoption of safety syringes
    • Increasing demand for vaccines and growing healthcare expenditure
  • Market Restraints
    • High cost of syringes and increasing incidence of needle stick injuries
  • Market Opportunities
    • Awareness associated with needlestick injuries coupled with continual improvements in healthcare practices in healthcare centers
    • Adoption of injectable drugs along with technological advancements in syringes
    • Rising cases in the usage of self-administration drugs such as insulin and development of biologics
  • Market Challenges
    • Availability of alternative drug delivery methods and sterility of injections

Porter's Five Forces: A Strategic Tool for Navigating the Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Syringes Market

A detailed market share analysis in the Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Syringes Market

A strategic analysis of the Syringes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Syringes Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Baxter Healthcare Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Codan Medizinische Gerate GmbH & Co KG, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., JMI Syringes & Medical Devices Limited, McKesson Medical-Surgical Inc., Medtronic PLC, Merit Medical Systems, Inc., Nipro Medical Corporation, Schott AG, and Smiths Medical by ICU Medical Inc..

Market Segmentation & Coverage

This research report categorizes the Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Disposable Syringes, Prefilled Syringes, and Sterilizable or Reusable Syringes.
  • Based on Application, market is studied across Blood Specimen Collection, Drug Delivery, and Vaccination.
  • Based on End-User, market is studied across Clinics, Family Practices, Fertility Patients, and Hospitals & HMOs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of surgical procedures
      • 5.1.1.2. High prevalence of chronic diseases, rising geriatric population, and increasing adoption of safety syringes
      • 5.1.1.3. Increasing demand for vaccines and growing healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of syringes and increasing incidence of needle stick injuries
    • 5.1.3. Opportunities
      • 5.1.3.1. Awareness associated with needlestick injuries coupled with continual improvements in healthcare practices in healthcare centers
      • 5.1.3.2. Adoption of injectable drugs along with technological advancements in syringes
      • 5.1.3.3. Rising cases in the usage of self-administration drugs such as insulin and development of biologics
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drug delivery methods and sterility of injections
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Syringes Market, by Type

  • 6.1. Introduction
  • 6.2. Disposable Syringes
  • 6.3. Prefilled Syringes
  • 6.4. Sterilizable or Reusable Syringes

7. Syringes Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Specimen Collection
  • 7.3. Drug Delivery
  • 7.4. Vaccination

8. Syringes Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Family Practices
  • 8.4. Fertility Patients
  • 8.5. Hospitals & HMOs

9. Americas Syringes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Syringes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Syringes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Baxter Healthcare Corporation
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Cardinal Health
  • 6. Codan Medizinische Gerate GmbH & Co KG
  • 7. Gerresheimer AG
  • 8. Hindustan Syringes & Medical Devices Ltd.
  • 9. JMI Syringes & Medical Devices Limited
  • 10. McKesson Medical-Surgical Inc.
  • 11. Medtronic PLC
  • 12. Merit Medical Systems, Inc.
  • 13. Nipro Medical Corporation
  • 14. Schott AG
  • 15. Smiths Medical by ICU Medical Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦